Results

Total Results: 3,091 records

Showing results for "drugs".

321. Brigham and Women’s Hospital CERT: Solving the Problem of Alert Fatigue To Minimize Medication Errors | Agency for Healthcare Research and Quality
     www.ahrq.gov/chain/research-tools/featured-certs/problem-of-alert-fatigue.html
     March 01, 2017 - The CERTs conduct research and provide education that will advance the optimal use of drugs, medical

322. Healthcare Research and Quality Act of 1999 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/hrqa99.pdf
     January 10, 2001 - —The Secretary, acting through the Director and in consultation with the Commissioner of Food and Drugs … , and devices; and ‘‘(III) risks of new uses and risks of combina- tions of drugs and biological products … , biological products, or devices; and ‘‘(II) the prevention of adverse effects of drugs, biological … ‘‘(B) The conduct of research on the comparative effectiveness, cost-effectiveness, and safety of drugs … be appropriate, except that a grant may not be expended to assist the Secretary in the review of new drugs

323. Chapter 1 | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/vision/resources/vision1.html
     October 01, 2002 - Continuing with the example of stroke, anticoagulant drugs may be administered to break up blood clots … evidence-based specialty. 8 Investigators call for an increase in systematic technology assessment of devices, drugs … benefit from laser surgery but do not get it. 24 Medical treatment for glaucoma is available, but drugs … are costly, must be taken for life, and have side effects although newer glaucoma drugs are associated

324. Risk Reduction and Systematic Error Management: Standardization of the Pediatric Chemotherapy Process (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-David_13.pdf
     March 19, 2008 - Children have a distinct physiology and an immature ability to metabolize drugs. … Children, especially small infants, have a unique physiology and an immature ability to metabolize drugs … administration regimens.1 , 2 Furthermore, weight-based dosing and toxicities inherent in the investigational drugs … American Academy of Pediatrics Committee on Drugs and Committee on Hospital Care.

325. Final Progress Report: Surveillance for Adverse Drug Events in Ambulatory Pediatrics (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/bailey-kilbridge-report.pdf
     January 01, 2024 - BACKGROUND AND SIGNIFICANCE: ADEs, defined as harm to patients by drugs,(8) comprise one of the largest … The range of possible ADE types and offending drugs is therefore potentially greater in pediatrics than … pediatric ADEs may more commonly involve electrolyte solutions, anti-infectives, immunomodulating drugs … proportion of ADEs due to electrolyte-wasting medications (diuretics, antimicrobials, antirejection drugs … Validation of automated event triggers using laboratory values related to two problem-prone drugs.

326. Decreasing Inappropriate Antibiotic Prescribing to Improve Patient Safety and Care | Agency for Healthcare Research and Quality
     www.ahrq.gov/funding/grantee-profiles/grtprofile-linder.html
     October 01, 2018 - ARIs and other conditions, is an important step in preserving the long-term effectiveness of these drugs

327. Plain Language Words | Agency for Healthcare Research and Quality
     www.ahrq.gov/health-literacy/improve/precautions/tool4e.html
     March 01, 2024 - finish, end for further instructions to find out what to do next formulary drugs … significant change maximum greatest, largest, most medications medicines, drugs

328. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=473
     January 01, 2024 - It found that both drugs were of similar effectiveness with respect to surgical rates, hospitalization … rates, and the percentage of patients remaining on the drugs after 26 weeks. … during pregnancy among Medicaid-enrolled women and recommended further safety evaluations of these drugs

329. From Quality Measures to Quality Care: Examples of Quality Improvement at Work | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/quality-measures/21st-century/challenges.html
     June 01, 2018 - Assessment Program worked to generate consensus and commitment from providers to increase use of life-saving drugs … flow meter readings and site visits to physician offices to promote prescribing of anti-inflammatory drugs … An AHCPR-sponsored Patient Outcome Research Team (PORT) studied the use of drugs called corticosteroids

330. CHIPRA Publications | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/chipra-publications.html
     July 01, 2015 - Paediatr Drugs 2013 Dec;15(6):441-7.

331. Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hougland_26.pdf
     October 01, 2011 - drug class thought responsible for these symptoms (e.g., E933.1, antineoplastic and immunosuppressive drugs … Adverse Drug Events Clinical side effects of drugs. … Adverse effects of anticonvulsants and anti-Parkinsonism drugs Total % 69.7 50.0 Inpatient 20/57 … Adverse effects of other drugs, biological, & medicinal substances in therapeutic use Total % 60.6 … Total % 8.6 60.7 a Classes with five or fewer reviewed cases are not reported. 14 due to drugs

332. Management of Clostridiodes difficile Infection (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/CDI-one-page.pdf
     November 01, 2019 - Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

333. Appendix, Data Collection Strategy, Assessment, and Process Evaluation | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/match/appendix/app-6a.html
     July 01, 2022 - If a patient will be provided/given any medications while under our care or prescribed any new drugs

334. Appendix, Data Collection Strategy, Assessment, and Process Evaluation | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/match/appendix/app-6a.html
     July 01, 2022 - If a patient will be provided/given any medications while under our care or prescribed any new drugs

335. Iowa Medicaid Uses AHRQ Research, Data to Improve Quality | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/ktcoe33.html
     October 01, 2014 - adult and pediatric psychiatrists, pediatricians, and pharmacists who specialize in behavioral health drugs

336. NICU Family Information Packet, Appendix B, Feeding Tubes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-tubes.pdf
     December 13, 2013 - ■ Consider prokinetic drugs. ■ Consider antiemetics.

337. Clinical Pharmacists in Emergency Medicine (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-fairbanks_20.pdf
     February 21, 2008 - These pharmacists are typically involved in assuring appropriate prescribing and administration of drugs … o Toxicology/drugs of abuse/overdose. • Some background in disaster management is preferred. … Keep informed of all local, State, and Federal laws covering the storage, handling, and dispensing of drugs … • Keep informed of the actions, side effects, and proper use of all new drugs as they are made commercially … available, as well as of all investigational drugs being studied at this institution

338. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=62
     January 01, 2024 - Primary Care Anderson KE , Polsky D , Dy S Prescribing of low- versus high-cost Part B drugs … TM) coverage as it relates to whether MA is associated with greater efficiency of prescribing Part B drugs … Four clinical scenarios were evaluated where multiple, similarly effective drugs exist: (1) anti-VEGF … treatment options exist, MA enrollees were more likely than TM enrollees to receive low-cost Part B drugs … Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare.

339. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=36
     January 01, 2024 - The purpose of this exploratory cross-sectional study was to pinpoint the attributes of drugs that correlate … Sixteen of the top 150 drugs had incomplete data, resulting in a primary study sample of 134 drugs. … proportion of total promotional spending allocated to direct-to-consumer advertising for the remaining 134 drugs … was an absolute 14.3% higher for drugs with low added clinical benefit compared to those with high added

340. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=16
     January 01, 2024 - added therapeutic benefit and domestic reference pricing into Medicare payment for expensive part B drugs … The objective of this retrospective analysis was to identify expensive Part B drugs and to consider the … The analysis showed that more than one-third of the expensive Part B drugs prescribed in 2019 offered … pricing based on added benefit assessment could be used to address the launch prices for expensive Part B drugs … added therapeutic benefit and domestic reference pricing into Medicare payment for expensive part B drugs